Clinical Director Dr. Michael Cooney is happy to be interviewed by media about drug-free pain management, chronic pain treatment and his nine years of success using Calmare scrambler therapy to reduce treatment- and medication-resistant pain.
He is a frequent guest author on pain management blogs and and chronic disease resource websites.
For interviews or requests for content, please reach out via our contact information below:
323 Union Ave., Rutherford, NJ 07070 | PH: 201-933-4440
Our collective goal is to help patients dramatically improve their quality of life by alleviating several types of diagnosed, treatment-resistant chronic pain.
Press Inquiries and Interview Requests:
Stephanie Duncan, MPW Communications, Inc.
732.763.1866 / Email: email@example.com
Calmare Therapy NJ USA:
Calmare Therapy is a non-invasive, non-pharmaceutical solution for pain control and drug resistant pain. It uses biophysical “scrambler” technology, a type of treatment for nerve pain that uses electrodes placed on the skin. Very low doses of electricity are transmitted from the electrodes through the skin to block the pain. Key points:
- Cleared by the FDA and European CE mark-certified
- Pain free
- No side effects
- It has been proven successful in the treatment of pain by leading research and medical studies.
How does Calmare work?
Calmare can relieve pain directly at the pain site without any reliance on medication. Via small electrodes, a ‘no-pain’ message is transmitted directly to the nerve for a period of about 35 minutes, on average. Regardless of severity, pain symptoms can be significantly lessened or even alleviated during the treatment series process. A full treatment process consists of one daily treatment for 10 days.
What medical conditions are appropriate for Calmare Treatment?
Chronic nerve pain / intractable pain including:
- CRPS / RSD
- Post herpetic neuralgia (PHN – complication from a shingles infection)
- Chemotherapy-induced peripheral neuropathy (CIPN)
- Diabetic nerve pain
- Post-surgical pain
- Phantom limb syndrome
File: Updated 6/2020